Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

OBJECTIVE: This article outlines the role of FDG PET/CT in patients with cervical carcinoma for evaluating tumor extent, assessing treatment response, and detecting disease recurrence. CONCLUSION: There is increasing evidence that FDG PET/CT has a role in the primary evaluation of cervical carcinoma-in particular, for evaluating lymph node status and distant metastatic disease. PET/CT is also helpful to determine prognosis, assess treatment response, and evaluate disease recurrence.

Original publication

DOI

10.2214/AJR.10.5084

Type

Journal article

Journal

AJR Am J Roentgenol

Publication Date

05/2011

Volume

196

Pages

1225 - 1233

Keywords

Carcinoma, Female, Fluorodeoxyglucose F18, Humans, Positron-Emission Tomography, Radiopharmaceuticals, Tomography, X-Ray Computed, Uterine Cervical Neoplasms